Freespira's Digital Therapeutic Now Available to Help Adolescents With Panic Attacks, Panic Disorder and PTSD Breakthrough medication-free treatment brings new hope to adolescents with mental health challenges News provided by Share this article Share this article KIRKLAND, Wash., March 2, 2021 /PRNewswire/ -- Freespira, Inc., maker of the first FDA-cleared digital therapeutic to significantly reduce or eliminate symptoms of panic attacks, panic disorder and post-traumatic stress disorder (PTSD) in only 28 days, today announced that its product is now available for adolescents, ages 13 years or older, in addition to adults who have already had access to the groundbreaking treatment.* The change comes at a critical time as the coronavirus pandemic intensifies a mental health crisis that had already afflicted millions of Americans. According to a Kaiser Family Foundation poll, 53 percent of U.S. adults report that their mental health has been negatively impacted by the virus. The Centers for Disease Control and Prevention (CDC) found that nearly 3 million children have been diagnosed with a serious emotional or behavioral health condition during the pandemic. U.S. hospitals also saw a 31% increase in the proportion of mental health emergency visits for adolescents ages 12 to 17 from April to October 2020.